Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study. [electronic resource]
Producer: 20170814Description: 2308-2315 p. digitalISSN:- 1528-0020
- Adolescent
- Adult
- Antilymphocyte Serum -- therapeutic use
- Bone Marrow -- drug effects
- Busulfan -- therapeutic use
- Child
- Child, Preschool
- Cyclophosphamide -- therapeutic use
- Fanconi Anemia -- immunology
- Female
- Graft vs Host Disease -- immunology
- Hematopoietic Stem Cell Transplantation
- Humans
- Lymphocyte Depletion
- Male
- Myeloablative Agonists -- therapeutic use
- Myelodysplastic Syndromes -- immunology
- Prospective Studies
- Siblings
- Survival Analysis
- T-Lymphocytes -- immunology
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Treatment Outcome
- Unrelated Donors
- Vidarabine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.